Schedule 13D ownership disclosure
Horizon Pharma plc
Security class unavailable · CUSIP: G4617B105
Event date: 2014-09-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 29.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-14-347300
- Form type
- SC 13D
- Filer
- Horizon Therapeutics Public Ltd Co
- CIK
- CIK 1492426
- Filed
- Sep 22, 2014
- Reporting period
- Sep 19, 2014
- Description
- Schedule 13D beneficial ownership